| Biologic Therapy |
0 |
0.94 |
| Lung Cancer |
0 |
0.91 |
| Genomic Medicine |
0 |
0.85 |
| Epidermal Growth Factor Receptor |
0 |
1 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Angiogenesis Inhibitors |
0 |
0.58 |
| Humanized Monoclonal Antibody |
0 |
0.52 |
| Brachial |
0 |
0.42 |
| Head and Neck Cancer |
0 |
0.25 |
| Small Cell Lung Cancer |
0 |
0.24 |
| Cancer |
0 |
0.21 |
| Metastasis |
0 |
0.2 |
| Tobacco Cessation |
0 |
0.18 |
| Lung |
0 |
0.16 |
| Smoking |
0 |
0.16 |
| Interstitial Lung Disease |
0 |
0.15 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.12 |
| HIV Infection |
0 |
0.12 |
| Tyrosine Kinase Inhibitor |
0 |
0.12 |
| Brain Metastasis |
0 |
0.1 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.1 |
| Biomarker |
0 |
0.05 |
| Brain |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Hand |
0 |
0.05 |
| Immunotherapy |
0 |
0.05 |
| Receptors |
0 |
0.05 |
| Tyrosine Kinase |
0 |
0.05 |